Gene: CCDC150
Official Full Name: coiled-coil domain containing 150provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18952 | CCDC150 Knockout cell line (HeLa) | Human | CCDC150 | 1:3~1:6 | Negative | Online Inquiry |
KO18953 | CCDC150 Knockout cell line (HCT 116) | Human | CCDC150 | 1:2~1:4 | Negative | Online Inquiry |
KO18954 | CCDC150 Knockout cell line (HEK293) | Human | CCDC150 | 1:3~1:6 | Negative | Online Inquiry |
KO18955 | CCDC150 Knockout cell line (A549) | Human | CCDC150 | 1:3~1:4 | Negative | Online Inquiry |
CCDC150 Gene Knockout Cell Lines are genetically engineered cell models designed to exhibit specific gene deficiencies, specifically targeting the CCDC150 gene. This innovative product leverages CRISPR-Cas9 technology to systematically disrupt the expression of the CCDC150 gene, providing researchers with a powerful tool for studying gene function and the molecular mechanisms underlying various cellular processes.
The key mechanism of these knockout cell lines involves the introduction of targeted double-strand breaks in the DNA at the CCDC150 locus, resulting in insertions or deletions that disrupt normal gene function. This creates an effective platform to investigate the role of CCDC150 in essential biological processes such as cellular proliferation, differentiation, and apoptosis. Understanding these pathways is crucial for advancing knowledge in various fields, including cancer research, developmental biology, and genetic disorders.
The scientific importance of CCDC150 knockout cell lines is underscored by their utility in both basic research and clinical applications. They serve as vital models for exploring gene interactions, assessing drug responses, and elucidating the genetic basis of diseases. Their applicability enhances the translational potential of preclinical studies and therapeutic developments.
One of the specific advantages of our CCDC150 Gene Knockout Cell Lines is their high fidelity and efficiency in gene editing, surpassing traditional knockout methods. Additionally, our cell lines are rigorously validated for specificity, ensuring that results obtained are directly attributable to the disruption of the CCDC150 gene rather than off-target effects. This precision empowers researchers to obtain reliable, reproducible results.
For researchers and clinicians, the value of utilizing CCDC150 Gene Knockout Cell Lines extends beyond mere experimentation; they represent an opportunity to drive forward the discovery of novel therapeutic targets and to refine treatment strategies. As a company dedicated to advancing biological research, we pride ourselves on our extensive expertise in cell line development and genetic engineering, delivering high-quality products that enhance research capabilities and facilitate scientific breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.